Ireland· IE-PA-PA1336/010/001
Angusta 25 microgram tablets
A misoprostol product containing misoprostol, registered in Ireland by Norgine B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Misoprostol is registered in 11 of 19 countries.
Countries holding a registration under ATC G02AD06 (misoprostol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Misoprostol · ATC G02AD06
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of misoprostol costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Misoprostol · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- US United States$0.72 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Misoprostol
- Manufacturer
- Norgine B.V.
- Country
- Ireland (IE)
- ATC code
- G02AD06
- ATC class
- Misoprostol
- Defined daily dose
- 0.2 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1336/010/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
245 interactions on record for misoprostol.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Misoprostol · interactions on record
245 records
- 10 moderate
- 6 minor
- 229 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Misoprostol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAngusta 25 microgram tablettenNorgine B.V.
- SpainANGUSTA 25 MICROGRAMOS COMPRIMIDOSNorgine B.V.
- FinlandAngustaNorgine B.V.
- SwedenAngusta 25 mikrogram TablettNorgine BV
- NorwayAngustaNorgine B.V.
- PolandAngustaNorgine B.V.
- CzechiaANGUSTANorgine B.V., Amsterdam
- United KingdomAngusta 25microgram tabletsNorgine Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Angusta®, Cyprostol
- Belgium · Angusta, Cytotec
- Bulgaria · Ангуста, Топогин
- Cyprus · Angusta, Misoone
- Czechia · Angusta, Mispregnol
- Germany · Angusta, Misoone
- Denmark · Angusta, Cytotec
- Estonia · Angusta, Gyxiny
- Spain · Angusta, Cytotec
- Finland · Angusta, Cytotec
- France · Angusta, Gymiso
- United Kingdom (Northern Ireland) · Angusta, Cytotec
- Greece · Angusta, Cytotec
- Croatia · Angusta, Mispregnol
- Hungary · Angusta
- Iceland · Angusta, Cytotec
- Italy · Angusta, Cytotec
- Lithuania · Gyxiny, Misoone
- Luxembourg · Angusta, Cytotec
- Latvia · Angusta, Gyxiny
- Malta · Angusta
- Netherlands · Angusta, Cytotec
- Norway · Angusta, Cytotec
- Poland · Angusta, Cytotec
- Portugal · Angusta, Cytotec
- Romania · Angusta, Topogyne
- Sweden · Angusta, Cytotec
- Slovenia · Angusta, Topogyne
- Slovakia · Angusta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5adbd539-cbf8-4613-90f1-ecf7d78467e0 GET /v1/drugs/5adbd539-cbf8-4613-90f1-ecf7d78467e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"G02AD06"
],
"strength": null,
"pa_number": "PA1336/010/001",
"substances": [
"Misoprostol"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "30/10/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about misoprostol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.